Displaying drugs 8526 - 8550 of 9230 in total
Lucitanib
Lucitanib has been used in trials studying the treatment of ER+, MBC, SCLC, HER2+, and NSCLC, among others.
Investigational
Mefruside
Experimental
Phenglutarimide
Experimental
Naftidrofuryl
Experimental
Carbaspirin calcium
Experimental
Investigational
Leriglitazone
Leriglitazone is under investigation in clinical trial NCT03917225 (A Clinical Study to Evaluate the Effect of MIN-102 on the Progression of Friedreich's Ataxia in Male and Female Patients).
Investigational
Methacrylyl-Coenzyme A
Experimental
Glutathione S-atrazine
Experimental
CoA-s-acetyl tryptamine
Experimental
S-P-Nitrobenzyloxycarbonylglutathione
Experimental
3-Hydroxybutyryl-Coenzyme A
Experimental
Olcegepant
Boehringer Ingelheim Pharmaceuticals’ olcegepant (BIBN 4096) is a selective Calcitonin Gene-Related Peptide (CGRP) antagonist, a new class of drugs in development for the treatment of acute migraine attacks. Olcegepant is undergoing phase II trials in Europe and the US, with preliminary results suggesting that CGRP antagonists may represent a potential...
Investigational
Nitromethyldethia coenzyme A
Experimental
Etarfolatide
Etarfolatide has been used in trials studying the treatment and diagnostic of Breast Neoplasms, Non Small Cell Lung Cancer, and Adenocarcinoma of the Lung.
Investigational
TAK-448
TAK-448 has been used in trials studying the treatment of Prostate Cancer, Low Testosterone, Prostatic Neoplasms, and Hypogonadotropic Hypogonadism.
Investigational
TRV-120027
TRV120027 has been used in trials studying the treatment of Heart Failure and Kidney Disease.
Investigational
Proglumetacin
Experimental
Domoic Acid
Experimental
3-Tyrosine
Experimental
4-Iodo-L-phenylalanine
Experimental
Trifluoromethionine
Experimental
Displaying drugs 8526 - 8550 of 9230 in total